Intelligent Asthma Monitoring Devices Market by Product and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

Intelligent Asthma Monitoring Devices Market by Product and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

  • October 2021 •
  • 183 pages •
  • Report ID: 6193559 •
  • Format: PDF
Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2021–2030

The global intelligent asthma monitoring devices market was valued at $180.5 million in 2020, and is projected to reach $1,696.7 million by 2030.
Asthma is a condition in which airways narrow and swell and may produce extra mucus, thus making breathing difficult and triggering cough. This further results in a whistling sound (wheezing) while breathing out and shortness of breath. It requires ongoing management using medication, and a person will often administer these medications using a range of devices, including inhalers and nebulizers. People will often use devices to effectively deliver asthma medication to the airways. Inhalers and nebulizers are the most common devices for administering asthma drugs.
Intelligent asthma monitoring devices are to monitor asthma and prevent asthma attacks & related complications. The growth of the global intelligent asthma monitoring devices market is driven by global increase in air pollution. In addition, increase in population susceptible to indoor air pollutants and alarming rise in prevalence of COPD & asthma globally notably contribute toward the market growth. Moreover, increase in adherence to smart inhalers and transformation from physician-centered to the patient-centered model, rise in collaboration between pharmaceutical companies and smart inhaler manufacturers, and surge in incidence of asthma cases fuel the growth of the market. However, misusing data and data privacy and resistance toward adoption of smart inhalers are expected to restrain the market growth. Conversely, increased focus toward advanced treatment protocols, significant unmet needs in respiratory care, and increase in healthcare expenditure in developing countries are expected to provide lucrative opportunities to the market players.
The key factors that drive the market growth include increase in indoor air pollutants, rise in prevalence of chronic obstructive pulmonary disease (COPD) & asthma, and surge in adoption of smart inhalers drive the growth of the global intelligent asthma monitoring devices market.
The global intelligent asthma monitoring devices market is segmented into product, end user, and region. Depending on product, the market is bifurcated into wearable asthma monitoring devices and smart inhalers. The smart inhalers segment is further segregated into inhalers and nebulizers. The inhaler segment is subsegmented into dry powdered inhalers and metered dose inhalers. On the basis of end user, the market is categorized into hospital, clinics, and home use.
Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players operating in the global intelligent asthma monitoring devices market are Adherium, Astrazeneca, Cohero Health Inc, Glaxosmithkline PLC, Health Care Originals, Koninklijke Philips N.V., Propeller Health, Teva Pharmaceuticals Industries Ltd., Vectura group Plc., and Volansys Technologies.

Key benefits for stakeholders
• The study provides an in-depth analysis of the global intelligent asthma monitoring devices market, with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided. The market forecast is studied from 2021 to 2030.
• Quantitative analysis of the industry from 2020 to 2030 is presented to enable stakeholders to capitalize on prevailing market opportunities.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key market segments

By Product
• Wearable asthma Monitoring Devices
• Smart Inhalers
o Inhalers
- Dry Powdered Inhalers (DPI’s)
- Metered Dose Inhalers (MDI’s)
o Nebulizers

By End User
• Hospitals
• Clinics
• Home Use

BY REGION
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Adherium
• Astrazeneca PLC
• Cohero Health Inc
• Glaxosmithkline PLC
• Health Care Originals
• Koninklijke Philips N.V
• Propeller Health
• Teva Pharmaceuticals Industries Ltd
• Vectura group Plc
• Volansys Technologies.